179 related articles for article (PubMed ID: 23400510)
1. Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis.
Takahashi S; Konishi M; Kinoshita T; Gotohda N; Kato Y; Saito N; Sugito M; Yoshino T
J Gastrointest Surg; 2013 May; 17(5):939-48. PubMed ID: 23400510
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
4. Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer.
Oguro S; Imamura H; Yoshimoto J; Ishizaki Y; Kawasaki S
J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):324-32. PubMed ID: 26946472
[TBL] [Abstract][Full Text] [Related]
5. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
[TBL] [Abstract][Full Text] [Related]
7. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.
Knowles B; Welsh FK; Chandrakumaran K; John TG; Rees M
HPB (Oxford); 2012 May; 14(5):298-309. PubMed ID: 22487067
[TBL] [Abstract][Full Text] [Related]
8. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
Kornprat P; Jarnagin WR; Gonen M; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
Ann Surg Oncol; 2007 Mar; 14(3):1151-60. PubMed ID: 17195913
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer.
Ishibashi K; Ishida H; Ohsawa T; Okada N; Kumamoto K; Haga N
Tech Coloproctol; 2013 Feb; 17(1):51-7. PubMed ID: 22936589
[TBL] [Abstract][Full Text] [Related]
10. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
[TBL] [Abstract][Full Text] [Related]
11. Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases.
Tanaka K; Kumamoto T; Nojiri K; Takeda K; Ichikawa Y; Endo I
World J Surg; 2012 Aug; 36(8):1832-41. PubMed ID: 22484568
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of oncologic prognostic factors in the decision-making of pre-hepatectomy chemotherapy for colorectal cancer hepatic metastasis: the priority of hepatectomy.
Chan KM; Wu TH; Wang YC; Lee CF; Wu TJ; Chou HS; Lee WC; Chiang JM; Chen JS
World J Surg Oncol; 2018 Feb; 16(1):24. PubMed ID: 29415722
[TBL] [Abstract][Full Text] [Related]
14. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M; Hatano E; Toda R; Nishino H; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokuka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2020 Aug; 27(8):496-509. PubMed ID: 32362018
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for early recurrence after curative hepatectomy for colorectal liver metastases.
Yamashita Y; Adachi E; Toh Y; Ohgaki K; Ikeda O; Oki E; Minami K; Sakaguchi Y; Tsujita E; Okamura T
Surg Today; 2011 Apr; 41(4):526-32. PubMed ID: 21431486
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.
Hayashi M; Inoue Y; Komeda K; Shimizu T; Asakuma M; Hirokawa F; Miyamoto Y; Okuda J; Takeshita A; Shibayama Y; Tanigawa N
BMC Surg; 2010 Sep; 10():27. PubMed ID: 20875094
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
18. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
[TBL] [Abstract][Full Text] [Related]
19. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
[TBL] [Abstract][Full Text] [Related]
20. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
